中国实用护理杂志
中國實用護理雜誌
중국실용호리잡지
CHINESE JOURNAL OF PRACTICAL NURSING
2008年
14期
4-6
,共3页
蒋冬梅%姜萍岚%虞玲丽%赖娟%李亚平%唐利立
蔣鼕梅%薑萍嵐%虞玲麗%賴娟%李亞平%唐利立
장동매%강평람%우령려%뢰연%리아평%당리립
临床路径%单病种%费用包干
臨床路徑%單病種%費用包榦
림상로경%단병충%비용포간
Clinical pathway%Single disease%Disease cost
目的 研究临床路径管理模式在单病种费用包干中的应用.方法 将2006年6月-2007年6月在中南大学湘雅医院乳腺科住院的患者随机分成2组,医保单病种费用包干患者为实验组,非医保单病种费用包干患者为对照组,2组均为40例,均为女性,2组入选患者的年龄、肿瘤部位、疾病分期、手术方式比较差异均无统计学意义.包干组按制订好的临床路径管理模式工作,非包干组按常规医疗护理模式工作.结果 包干组的平均住院日、平均候手术日、平均住院费用均低于非包干组(P<0.05),包干组的健康知识掌握度、患者的满意度高于非包干组(P<0.05).结论 对医保费用包干患者实施临床路径管理能有效控制费用和保证质量,认为单病种患者实施费用包干是切实可行的.
目的 研究臨床路徑管理模式在單病種費用包榦中的應用.方法 將2006年6月-2007年6月在中南大學湘雅醫院乳腺科住院的患者隨機分成2組,醫保單病種費用包榦患者為實驗組,非醫保單病種費用包榦患者為對照組,2組均為40例,均為女性,2組入選患者的年齡、腫瘤部位、疾病分期、手術方式比較差異均無統計學意義.包榦組按製訂好的臨床路徑管理模式工作,非包榦組按常規醫療護理模式工作.結果 包榦組的平均住院日、平均候手術日、平均住院費用均低于非包榦組(P<0.05),包榦組的健康知識掌握度、患者的滿意度高于非包榦組(P<0.05).結論 對醫保費用包榦患者實施臨床路徑管理能有效控製費用和保證質量,認為單病種患者實施費用包榦是切實可行的.
목적 연구림상로경관리모식재단병충비용포간중적응용.방법 장2006년6월-2007년6월재중남대학상아의원유선과주원적환자수궤분성2조,의보단병충비용포간환자위실험조,비의보단병충비용포간환자위대조조,2조균위40례,균위녀성,2조입선환자적년령、종류부위、질병분기、수술방식비교차이균무통계학의의.포간조안제정호적림상로경관리모식공작,비포간조안상규의료호리모식공작.결과 포간조적평균주원일、평균후수술일、평균주원비용균저우비포간조(P<0.05),포간조적건강지식장악도、환자적만의도고우비포간조(P<0.05).결론 대의보비용포간환자실시림상로경관리능유효공제비용화보증질량,인위단병충환자실시비용포간시절실가행적.
Objective To explore the application of clinical pathway in the management of single disease cost. Methods Inpatients with breast cancer from June 2006 to June 2007 were divided into the test group and the control group according to different payment models.Patients in the test group had medical insurance while patients in the control group did not.The general data in the two groups had no statistical difference.The test group were given nursing intervention by clinical pathway while the control group received routine nursing measures. Results The mean inhospital days,mean days waiting for operations and mean inhospital expenses in the test group were shorter or lower than those in the control group (P < 0.05).The mastering degree of health knowledge and the satisfaction degree of patients in the test group were higher than those in the control group (P < 0.05). Conclusions The application of chnical pathway in the single disease cost patients with medical insurance could effectively control the medical expenses and guarantee the quality.So we consider that the application of clinical pathway in single disease cost is applicable.